<

 
Data updated 2025-07-21 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date09703808.7 (espacenet)  (Federated)  (European Patent Register), 20090113
Patent/reg. no. and dateDK/EP 2252581, 20120620
Publication date20101124
Priority no. and dateEP 08380012, 20080122, US 39121 P, 20080325
EP pub. no. and date EP 2252581 20101124
Effective date
Applicant/ownerELI LILLY AND COMPANY, Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.P81202893DK00E
InventorDIAZ BUEZO, Nuria, Lilly S.A.
Avenida de la Industria 30
28108 Alcobendas
Madrid, ES,
MCKINZIE, David, Lee, Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US,
MITCH, Charles, Howard, Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US,
PEDREGAL-TERCERO, Concepcion, Lilly S.A.
Avenida de la Industria 30
28108 Alcobendas
Madrid, ES
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/40 (2006.01) , A61P 25/32 (2006.01) , C07D 207/08 (2006.01) 
TitleKAPPA-SELEKTIV OPIOIDRECEPTORANTAGONIST
Int. application no.US2009030811
Int. publication no.WO2009094260
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact